Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Substance P Workflows for Neuroimmune Research
2026-09-29
Build reproducible Substance P assays for pain transmission research, NK-1 receptor signaling, and immune response modulation without introducing DMSO or ethanol confounders. A separate excitation–emission matrix workflow shows how preprocessing and machine learning can improve classification in complex bioaerosol samples, while clearly defining the limits of transferring that approach to peptide research.
-
Phosphorylated NPY1R in Intracranial Aneurysm Progression
2026-09-29
A December 2024 study identifies phosphorylated NPY1R as a regulator connecting vascular smooth muscle cell phenotypic transition, inflammatory signaling, and macrophage infiltration during intracranial aneurysm progression. Its combination of human tissue analysis, mouse modeling, molecular assays, and macrophage ablation provides a mechanistic framework for interpreting NPY1R as more than a disease-associated marker.
-
Functional Engineered Esophagus in a Large-Animal Model
2026-09-28
This study integrates autologous myogenic and stromal cells, a decellularized porcine scaffold, bioreactor conditioning, temporary intraluminal stenting, and vascularizing pleural coverage to repair circumferential esophageal defects in growing minipigs. The resulting grafts showed progressive neuromuscular regeneration, vascularization, oral-feeding capability, and secondary peristalsis, although survival to the six-month endpoint was 63% and further validation is needed.
-
EdU Flow Cytometry Assay Kits (Cy5) in Wound Research
2026-09-28
Use EdU incorporation to test whether wound-repair or drug-treatment conditions change the fraction of cells actively synthesizing DNA. The Cy5 click-chemistry workflow offers an endpoint S-phase readout that can be paired with cell-cycle dyes and selected antibody panels—without the DNA-denaturation step commonly used in BrdU assays.
-
NADPH Oxidase ROS Drive Neonatal Arterial Contraction
2026-09-27
In saphenous arteries from early postnatal rats, NADPH oxidase-derived reactive oxygen species (ROS) enhanced agonist-induced contraction through L-type voltage-gated calcium channels. Pharmacological experiments argued against Rho-kinase, PKC, or Src-kinase as necessary mediators of this ROS effect, refining the mechanisms proposed for age-dependent vascular tone.
-
Angiotensin II: From GPCR Signal to Vascular Disease
2026-09-26
Angiotensin II links GPCR signaling to vascular stress and inflammation. This article connects mechanistic evidence on Cx43/NF-κB signaling with practical guidance for designing cardiovascular and macrophage studies.
-
nor-NOHA: Separating Arginine and Lipid Signaling
2026-09-25
nor-NOHA acetate is a reversible arginase inhibitor that lets researchers test whether arginine metabolism contributes to a phenotype alongside lipid-driven immune signaling. This article connects its established biochemical and model-system evidence to the CD36–AML findings while defining the limits of that cross-domain interpretation.
-
Polybrene for Metabolic-Pathway Gene Delivery
2026-09-25
Polybrene (Hexadimethrine Bromide) can improve viral delivery when researchers need to perturb metabolic regulators such as TCAIM, but it is a delivery aid—not a metabolic probe. This guide pairs a careful transduction workflow with assay choices inspired by the finding that TCAIM lowers OGDH protein levels.
-
Coronavirus Macrodomains Counter PARP Antiviral Defense
2026-09-24
Grunewald and colleagues show that coronavirus macrodomain function helps the virus resist PARP-dependent restriction and interferon induction. By combining viral mutants, pan-PARP inhibition, and PARP12/PARP14 knockdown, the study links host ADP-ribosylation to antiviral activity while identifying important limits for interpreting inhibitor experiments.
-
Indometacin Sodium in Applied Research Workflows
2026-09-24
Indometacin Sodium provides a practical way to probe prostaglandin-dependent biology, from inflammation assays to follicular rupture and cell-differentiation models. A randomized IVF trial offers a useful lesson in timing and patient-context stratification—but its overall result was not significant, so translational claims should remain measured.
-
Ceftolozane-Tazobactam in Nosocomial Pneumonia
2026-09-23
This review connects ceftolozane’s structural features and antipseudomonal activity with pharmacokinetic–pharmacodynamic considerations and clinical evidence in hospital-acquired and ventilator-associated pneumonia. It highlights non-inferiority to meropenem in ASPECT-NP while emphasizing that post-hoc subgroup findings and surveillance results must be interpreted in their clinical and epidemiological context.
-
Oleic Acid Workflows for Lipid Metabolism Research
2026-09-23
Build reproducible hepatocyte lipid-loading models with Oleic Acid (C18:1(9Z)) while separating fatty-acid stress from pathway-specific rescue. This practical guide translates hepatic ischemia-reperfusion findings into dosing, controls, mechanistic readouts, and troubleshooting strategies.
-
Thermal-Protective Hydrogel for Tumor Ablation
2026-09-22
The reference study introduces an injectable MR@CaP@HA hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod. This integrated design addresses both incomplete ablation and weak post-ablation immunity, producing strong dendritic-cell and macrophage responses and complete tumor eradication in a subset of treated animals.
-
Angiotensin 1/2 (5-7): Assay Design Guide
2026-09-22
Explore how Angiotensin 1/2 (5-7), the H2N-Ile-His-Pro-OH peptide, can support better-designed cardiovascular and receptor-binding studies. This guide emphasizes molecular identity, assay controls, evidence boundaries, and practical interpretation rather than repeating standard peptide protocols.
-
Stable-Isotope UHPLC–MS/MS for Methylated Nucleosides
2026-09-21
The reference study introduces a stable isotope-diluted UHPLC–ESI-MS/MS workflow for sensitive, quantitative measurement of methylated purine nucleosides in cellular samples. Its combination of ammonium bicarbonate-assisted ionization, chromatographic isomer separation, and methanol–SPE cleanup addresses matrix suppression and supports intracellular nucleoside biomarker research.